Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1995-03-23
1997-09-02
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 165, 424 177, A61K 5100
Patent
active
056628820
ABSTRACT:
The present invention relates to novel radiopharmaceutical imaging agents having non-stannous reductants. The present invention further relates to kits for forming radiopharmaceutical imaging agents, such kits including non-stannous reducing agents.
REFERENCES:
patent: 3749556 (1973-07-01), Barak
patent: 4208398 (1980-06-01), Kubiatowicz et al.
patent: 4272503 (1981-06-01), Camin et al.
patent: 4314986 (1982-02-01), Ruddock
patent: 4642229 (1987-02-01), Cumming et al.
patent: 4795626 (1989-01-01), Deutsch et al.
patent: 4810486 (1989-03-01), Kelly et al.
patent: 4873074 (1989-10-01), Chia et al.
patent: 4925650 (1990-05-01), Nosco et al.
patent: 4957728 (1990-09-01), Deutsch et al.
patent: 5069900 (1991-12-01), Linder
patent: 5112594 (1992-05-01), Woulfe et al.
patent: 5202109 (1993-04-01), Fritzberg et al.
patent: 5300280 (1994-04-01), DeRosch et al.
patent: 5317091 (1994-05-01), Subramanian
Brodack James W.
DeRosch Mark A.
Deutsch Edward A.
Dyszlewski Mary Marmion
Chapman Lara E.
Guffey Wendell Ray
Hollinden Gary E.
Mallinckrodt Medical Inc.
McBride Thomas P.
LandOfFree
Radiopharmaceutical formulations having non-stannous reductants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiopharmaceutical formulations having non-stannous reductants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiopharmaceutical formulations having non-stannous reductants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-305884